| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 6e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 1e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0009 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.001 |